Global HPV Vaccines Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global HPV Vaccines Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Human papillomavirus (HPV) vaccine is a vaccine that prevent infection by certain types of human papillomavirus (HPV). The existing human papillomavirus vaccine can prevent two, four or nine types of HPV. All HPV vaccines can at least prevent HPV type 16 and type 18, and these two vaccines have the greatest risk of cervical cancer. It is estimated that HPV vaccine can prevent 70% of cervical cancer, 80% of anal cancer, 60% of vaginal cancer and 40% of vulvar cancer, and it shows more than 90% efficacy in preventing HPV-positive oropharyngeal cancer.

Market Overview:

The latest research study on the global HPV Vaccines market finds that the global HPV Vaccines market reached a value of USD 4952.62 million in 2022. It’s expected that the market will achieve USD 15399.91 million by 2028, exhibiting a CAGR of 20.81% during the forecast period.

In 2021, economic and political risks will be intertwined. Trade tensions continue to pose major risks to the global economy, and the outbreak of the new coronavirus (Covid-19) has also disrupted trade and supply chains. The global death toll from the new crown epidemic has exceeded five million, and this number continues to rise. In addition, many more people suffer from severe illness. This year, it is estimated that nearly 90 million people will fall into extreme poverty. Low-income people or people living in areas with high unemployment need income to make ends meet, such as food and rent. There is no additional expenditure for non-necessities for the time being. However, as the epidemic is brought under control in many places and the economy is gradually recovering, more and more people will reserve more expenditures for health problems. With the re-prosperity of the global economy and people's increasing attention to health. HPV Vaccines industry will develop accordingly.

Region Overview:

In 2022, the share of the HPV Vaccines market in East Asia stood at 58.74%.

Company Overview:

Merck & Co., Inc. is one of the major players operating in the HPV Vaccines market, holding a share of 89.2% in 2021.

Merck & Co., Inc.

Merck is a leading global biopharmaceutical company that has been inventing for life for more than a century, bringing forward medicines and vaccines for many of the world’s most challenging diseases. Through prescription medicines, vaccines, biologic therapies and animal health products, Merck work with customers and operate in more than 140 countries to deliver innovative health solutions.

GSK

GlaxoSmithKline plc (GSK) is a British multinational pharmaceutical company headquartered in London, England. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham.

Segmentation Overview:

By type, Quadrivalent segment accounted for the largest share of market in 2022.

Application Overview:

By application, the Hospital & Retail Pharmacies segment occupied the biggest share from 2018 to 2022.

Key Companies in the global HPV Vaccines market covered in Chapter 3:

Merck & Co., Inc.
Inovio Pharmaceuticals
GSK
Serum Institute of India Pvt. Ltd.
Bavarian Nordic
Wantai Biological

In Chapter 4 and Chapter 14.2, on the basis of types, the HPV Vaccines market from 2018 to 2029 is primarily split into:

Bivalent
Quadrivalent
Nonavalent

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the HPV Vaccines market from 2018 to 2029 covers:

Hospital & Retail Pharmacies
Government Suppliers
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)